Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04913805

Matching Perfusion and Metabolic Activity in HFpEF

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
53 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will test whether pharmacologic agents that increase perfusion \[Potassium Nitrate (KNO3)\], with and without additional supplements that may improve mitochondrial function \[Propionyl-L-Carnitine (PLC) and Nicotinamide Riboside (NR)\], improve submaximal exercise endurance and skeletal muscle oxidative phosphorylation capacity (SkM OxPhos) in participants with Heart Failure with Preserved Ejection Fraction (HFpEF).

Detailed description

This study will test whether Potassium Nitrate (KNO3), with and without Propionyl-L-Carnitine (PLC) and Nicotinamide Riboside (NR), improves submaximal exercise endurance and skeletal muscle oxidative phosphorylation capacity (SkM OxPhos) in participants with Heart Failure with Preserved Ejection Fraction (HFpEF). Additionally, the study will test whether the response to supplemental oxygen during a standardized MRI assessment of skeletal muscle oxidative capacity can identify HFpEF individuals who preferentially will benefit from either KNO3 alone or the combination of pharmacologic agents (KNO3 + PLC + NR)

Conditions

Interventions

TypeNameDescription
DRUGPotassium NitratePotassium Nitrate is the active intervention that may increase blood flow to exercising muscle
DRUGPotassium Nitrate + Propionyl-L-Carnitine + Nicotinamide RibosidePotassium Nitrate + Propionyl-L-Carnitine + Nicotinamide Riboside will be used as a combination intervention to both increase blood flow (KNO3) and mitochondrial function (PLC + NR)
OTHERPotassium ChlorideActive control

Timeline

Start date
2021-10-11
Primary completion
2027-05-01
Completion
2027-05-01
First posted
2021-06-04
Last updated
2025-05-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04913805. Inclusion in this directory is not an endorsement.